Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 5
Author: Axis Direct

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	20 Sep 2025	Dr. Reddy's Labs	Consensus Share Price Target	1321.70	1285.13	-	-2.77	hold	pdf Detailed Estimates
	29 Jun 2022	Dr. Reddy's Labs	Axis Direct Target	1321.70	4750.00	4364.35 (-69.72%)	Target met	Buy	pdf post cache	Broker Report Company Update:Dr Reddys Labs Axis Direct We recommend a BUY rating on the stock with a TP of Rs 4,750. pdf Copy Link Share on Share on Share on Share on Alert
	24 Jun 2022	Dr. Reddy's Labs	ICICI Securities Limited Target	1321.70	4925.00	4294.90 (-69.23%)	Target met	Buy	pdf post cache	Broker Report Investor meet highlights ICICI Securities Limited DRL has devised a two-pronged strategy to drive long-term growth, classified as Horizon 1 and Horizon 2. Horizon 1 – Growing the core, short-medium term drivers of growth. ? Horizon 2 Building the future, short-long term drivers of growth pdf Copy Link Share on Share on Share on Share on Alert
	23 Jun 2022	Dr. Reddy's Labs	Geojit BNP Paribas Target	1321.70	5026.00	4309.65 (-69.33%)	Pre-Bonus/ Split	Buy	pdf post cache	Broker Report DR. REDDY'S LABORATARIES Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	22 Jun 2022	Dr. Reddy's Labs	BOB Capital Markets Ltd.	1321.70	4450.00	4309.65 (-69.33%)	Target met	Hold	pdf post cache	Broker Report Dr Reddy's Labs (HOLD): Investor Day Peek into the future BOB Capital Markets Ltd. DRRD unveiled a framework to make its business future ready pdf Copy Link Share on Share on Share on Share on Alert
	22 Jun 2022	Dr. Reddy's Labs	Prabhudas Lilladhar Reco Target	1321.70	4900.00	4294.90 (-69.23%)	Target met	Buy	pdf post cache	Broker Report DR REDDY'S LABS Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	22 Jun 2022	Dr. Reddy's Labs	ICICI Direct Target	1321.70	4960.00	4260.90 (-68.98%)	Target met	Buy	pdf post cache	Broker Report Dr Reddy's Laboratories ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	21 May 2022	Dr. Reddy's Labs	Sharekhan Target	1321.70	5550.00	4390.50 (-69.90%)	Pre-Bonus/ Split	Buy	pdf post cache	Broker Report Dr Reddys Labs Sharekhan pdf Copy Link Share on Share on Share on Share on Alert
	20 May 2022	Dr. Reddy's Labs	Axis Direct Target	1321.70	4500.00	4249.10 (-68.89%)	Target met	Buy	pdf post cache	Broker Report Result Update:Dr Reddys Labs Axis Direct The company is building a global pipeline of biosimilars, developments of NCE for Immuno-oncology, and building up a Neutraceuticals portfolio, vaccines, CDMO, and digital healthcare platforms. However, high inflation could decrease margins prompting us to reduce TP to Rs 4,500/share. pdf Copy Link Share on Share on Share on Share on Alert
	20 May 2022	Dr. Reddy's Labs	SMC online	1321.70		4249.10 (-68.89%)	Pre-Bonus/ Split	Results Update	pdf post cache	Broker Report Dr. Reddy`s Laboratories SMC online pdf Copy Link Share on Share on Share on Share on Alert
	20 May 2022	Dr. Reddy's Labs	BOB Capital Markets Ltd. Target	1321.70	4450.00	4249.10 (-68.89%)	Target met	Hold	pdf post cache	Broker Report Dr Reddy's Labs (HOLD): Operating performance in line; impairment weighs down profit BOB Capital Markets Ltd. India, Russia, US and one-off opportunities drove 15% YoY sales growth in Q4; non-core brands divested in Russia and India pdf Copy Link Share on Share on Share on Share on Alert
more loading

29.58% Gain from 52W Low

Dr. Reddy's Laboratories Ltd. share price target

Dr. Reddy's Laboratories Ltd. has an average share price target of 1278.56. The consensus estimate represents a downside of -3.26% from the last price of 1321.70. View 18 reports from 9 analysts offering long-term price targets for Dr. Reddy's Laboratories Ltd..

Company Update:Dr Reddys Labs

Investor meet highlights

DR. REDDY'S LABORATARIES

Dr Reddy's Labs (HOLD): Investor Day Peek into the future

DR REDDY'S LABS

Dr Reddy's Laboratories

Dr Reddys Labs

Result Update:Dr Reddys Labs

Dr. Reddy`s Laboratories

Dr Reddy's Labs (HOLD): Operating performance in line; impairment weighs down profit

Advisor Screeners